|1.8 -0.03 (-1.64%)||11-29 10:11|
|Targets||6-month :||2.88||1-year :||3.36|
|Resists||First :||2.47||Second :||2.88|
|Supports||First :||1.33||Second :||0.62|
|MAs||MA(5) :||1.92||MA(20) :||1.56|
|MA(100) :||1.71||MA(250) :||6.23|
|MACD||MACD :||0.2||Signal :||0.1|
|%K %D||K(14,3) :||69.2||D(3) :||72.3|
|52-week||High :||18.6||Low :||0.5|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ INVO ] has closed below upper band by 43.2%. Bollinger Bands are 19.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|If tomorrow:||Open lower||Open higher|
|High:||2.04 - 2.05||2.05 - 2.06|
|Low:||1.68 - 1.69||1.69 - 1.7|
|Close:||1.81 - 1.83||1.83 - 1.85|
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
|Shares Out||0 (M)|
|Shares Float||2 (M)|
|Held by Insiders||2.22e+006 (%)|
|Held by Institutions||0 (%)|
|Shares Short||123 (K)|
|Shares Short P.Month||0 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||0|
|Profit Margin||0 %|
|Operating Margin||-91 %|
|Return on Assets (ttm)||-41.3 %|
|Return on Equity (ttm)||-1 %|
|Qtrly Rev. Growth||1.92e+006 %|
|Gross Profit (p.s.)||241.76|
|Sales Per Share||46.96|
|Qtrly Earnings Growth||-10.4 %|
|Operating Cash Flow||0 (M)|
|Levered Free Cash Flow||-5 (M)|
|Price to Book value||0|
|Price to Sales||0.03|
|Price to Cash Flow||15.61|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|